D.E. Shaw & Co’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,000
Closed -$3.36M 4694
2025
Q3
$3.36M Buy
+50,000
New +$3.96M ﹤0.01% 2552
2025
Q1
Sell
-20,000
Closed -$1.56M 4398
2024
Q4
$1.56M Hold
20,000
﹤0.01% 2914
2024
Q3
$1.34M Sell
20,000
-4,200
-17% -$345K ﹤0.01% 3044
2024
Q2
$2.74M Buy
24,200
+2,500
+12% +$316K ﹤0.01% 2346
2024
Q1
$3.01M Sell
21,700
-12,400
-36% -$1.56M ﹤0.01% 2296
2023
Q4
$4.23M Buy
34,100
+20,000
+142% +$2.04M 0.01% 2044
2023
Q3
$1.32M Hold
14,100
﹤0.01% 2893
2023
Q2
$1.81M Sell
14,100
-75,000
-84% -$9.07M ﹤0.01% 2687
2023
Q1
$10.4M Sell
89,100
-195,900
-69% -$21.9M 0.02% 1336
2022
Q4
$32.3M Sell
285,000
-28,000
-9% -$3.07M 0.05% 635
2022
Q3
$25.2M Buy
313,000
+42,200
+16% +$3.57M 0.04% 716
2022
Q2
$20.2M Sell
270,800
-59,200
-18% -$5.4M 0.03% 863
2022
Q1
$42.2M Sell
330,000
-317,200
-49% -$34.7M 0.06% 567
2021
Q4
$86.9M Sell
647,200
-13,200
-2% -$1.9M 0.11% 319
2021
Q3
$90.3M Buy
660,400
+203,200
+44% +$25.6M 0.12% 289
2021
Q2
$48.8M Buy
457,200
+167,600
+58% +$16.1M 0.06% 556
2021
Q1
$26M Sell
289,600
-201,600
-41% -$18.9M 0.03% 790
2020
Q4
$45.4M Sell
491,200
-8,400
-2% -$750K 0.05% 532
2020
Q3
$51.5M Buy
499,600
+113,200
+29% +$11.8M 0.07% 411
2020
Q2
$39.2M Buy
386,400
+138,400
+56% +$12.4M 0.06% 455
2020
Q1
$16.7M Sell
248,000
-96,400
-28% -$6M 0.03% 726
2019
Q4
$18.8M Buy
344,400
+244,400
+244% +$11.6M 0.03% 846
2019
Q3
$3.73M Hold
100,000
0.01% 1868
2019
Q2
$3.75M Hold
100,000
0.01% 1802
2019
Q1
$2.98M Hold
100,000
﹤0.01% 1883
2018
Q4
$3M Buy
100,000
+20,000
+25% +$634K 0.01% 1858
2018
Q3
$2.86M Buy
+80,000
New +$2.48M ﹤0.01% 1949
2015
Q4
Sell
-79,200
Closed -$1.7M 3842
2015
Q3
$1.7M Hold
79,200
﹤0.01% 2216
2015
Q2
$1.58M Buy
+79,200
New +$1.39M ﹤0.01% 2378
2014
Q2
Sell
-24,800
Closed -$256K 4286
2014
Q1
$256K Hold
24,800
﹤0.01% 3983
2013
Q4
$220K Buy
+24,800
New +$196K ﹤0.01% 4220

Other funds holding DXCM